Lucia Lopez Corral

Universidad de Salamanca

Spain

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Virology

10%

Tissue Engineering

10%

Regulatory T Cells

30%

Graft-versus-host Disease

30%

Cell Therapy

30%

Flow Cytometry

20%

Antiviral Therapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working party

Article Link

Year:

2025

GvHD prophylaxis with tacrolimus, sirolimus, and mycophenolate mofetil after reduced intensity conditioning hematopoietic stem cell allogeneic transplantation

Article Link

Year:

2025

The use of MSCs in steroid-refractory acute GvHD in Europe: a survey from the EBMT cellular therapy & immunobiology working party

Article Link

Year:

2025

Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy

Article Link

Year:

2024

A research center's experience of T-cell-redirecting therapies in triple-class refractory multiple myeloma.

Article Link

Year:

2024

Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC.

Article Link

Year:

2024

Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT)

Article Link

Year:

2024

Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMO.

Article Link

Year:

2024

Young (<35 years) haploidentical versus old (≥35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Article Link

Year:

2024

Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

Article Link

Year:

2024

Collaborators9

Verónica González-Calle

University Hospital of Salamanca

SPAIN

Sara Villar

Clinica Universidad de Navarra

SPAIN

Michael Daskalakis

Assistant Professor, Head of Cellular Therapy Division, Director of autologous Stem Cell Program Inselspital

Inselspital Universitätsspital Bern

SWITZERLAND

Alicia Roldán Pérez

Universidad Europea de Madrid SLU

SPAIN

Javier Briones Meijide

Professor

University of Barcelona

SPAIN

albert esquirol

SPAIN

Simona Sica

ITALY

Simona Pagliuca

FRANCE

Nina Worel

Medical University of Vienna

AUSTRIA

How do I reach out?

Meet Kite AI